679.99p+9.99 (+1.49%)23 Apr 2021, 08:05
Find out how to deal online from £1.50 in a SIPP, ISA or Dealing account.
Jump to:

Tristel PLC Fundamentals

Company NameTristel PLCLast Updated2021-04-23
IndustryMedical Instruments & SuppliesSectorHealthcare
Shares in Issue47.058 mMarket Cap£319.99 m
PE Ratio57.80Dividend per Share£0.06
Dividend Yield1Dividend Cover1.86
EPS£0.11EPS Growth (%)0.24
PEG0DPS Growth (%)0.1633
Debt Ratio0.1509Debt Equity Ratio0.1789
Asset Equity Ratio1.3828Cash Equity Ratio0.2512
Quick Ratio2.4793Current Ratio3.23
Price To Book Value10.8460ROCE0

Tristel PLC Dividends

TypeEx-DatePay DateCurrencyNet DividendYear Total

Tristel PLC Company Financials

Tangible Assets£8.08 m£1.47 m£1.33 m
Intangible Assets£13.25 m£12.74 m£6.95 m
Total Fixed Assets£23.68 m£15.79 m£9.31 m
Stocks£4.62 m£2.96 m£2.28 m
Debtors£5.22 m£4.45 m£3.70 m
Cash & Equivalents£6.21 m£4.17 m£6.66 m
Other Assets000
Total Assets£40.93 m£28.29 m£22.54 m
Creditors within 1 year£6.67 m£4.38 m£3.91 m
Creditors after 1 year£5.80 m£550,000.00£205,000.00
Other Liabilities000
Total Liabilities£12.47 m£4.93 m£4.11 m
Net assets£28.46 m£23.36 m£18.43 m
Called up share capital£453,000.00£446,000.00£432,000.00
Share Premium£12.63 m£11.43 m£11.06 m
Profit / Loss£6.64 m£4.75 m£4.01 m
Other Equity£28.46 m£23.35 m£18.42 m
Preference & Minorities£7,000.00£7,000.00£7,000.00
Total Capital Employed£28.46 m£23.36 m£18.43 m
Debt Ratio£0.1500
Assets / Equity1.38281.38281.3828
Cash / Equity0.25120.25120.2512
Cash Flow202020192018
Cash from operating activities£6.99 m£5.49 m£4.50 m
Cashflow before financing£4.97 m£3.66 m£3.04 m
Increase in Cash£1.99 m-£2.51 m£1.59 m
Turnover£31.68 m£26.17 m£22.22 m
Cost of sales£6.43 m£5.50 m£5.04 m
Gross Profit£25.25 m£20.66 m£17.18 m
Operating Profit£6.80 m£4.70 m£3.98 m
Pre-Tax profit£6.64 m£4.75 m£4.01 m

Tristel PLC Company Background

ActivitiesTristel PLC is a player in the healthcare platform. The company is a manufacturer of infection prevention and contamination control products. Its core product candidate is a chlorine dioxide formulation. Its operating segments include Hospital medical device decontamination and Hospital environmental surface disinfection. It caters to three market avenues: The Human Healthcare market, The Contamination Control market, and the Animal Healthcare market. The Human Healthcare division deals with hospital infection prevention and accounts for most of the company's revenues.
Latest Interim Date22 Feb 2021
Latest Fiscal Year End Date19 Oct 2020

Tristel PLC Directors

2006-11-01Mr. Peter Charles Anderson ClarkeNon-Executive Director
2014-10-16Mr. Bruce GreenNon-Executive Director
2021-04-06Mr. Paul Christopher SwinneyExecutive Director,Chief Executive
2012-12-20Mr. Peter Francis Howard StephensNon-Executive Director
2018-10-17Mr. Francisco Angel SolerNon-Executive Director,Chairman (Interim)
2020-12-15Mr. Paul Martin BarnesNon-Executive Director
2011-08-09Mr. Antonio SolerNon-Executive Director
2021-03-05Ms. Elizabeth Dixon Executive Director,Finance Director and Company Secretary
2014-10-15Mr. Christopher Hadley SamlerNon-Executive Director,Chairman
2021-03-05Mr. David William Edmund OrrNon-Executive Director
2021-03-04Ms. Isabel Josephine Sutherland NapperNon-Executive Director
2020-10-21Mr. Bart Victor Margaretha LeemansExecutive Director

Tristel PLC Contact Details

Company NameTristel PLC
AddressFordham Road, Unit 1B, Lynx Business Park, Newmarket, Snailwell, CB8 7NY
Telephone+44 1638721500

Tristel PLC Advisors

Phone+44 2078614000
AuditorGrant Thornton UK LLP
Phone+44 1223225600
Fax+44 1223225619
RegistrarComputershare Investor Services PLC
Phone+44 3707020003
Fax+44 3707036101
Phone+44 2072200500
Fax+44 2076001659
Financial PR AdviserWalbrook PR
Phone+44 2079338780
Fax+44 2079338781
SolicitorGreene & Greene
Phone+44 1284762211
Fax+44 1284717499
Nominated AdviserFinnCap
Phone+44 2072200500
Fax+44 2076001659